Latest stories on JHPCY
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
PR Newswire67 · bullishproduct/pr
Jiangsu Hengrui Pharmaceuticals Co.,Ltd 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings